T2 Biosystems Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
T2 Biosystems is a Lexington, Massachusetts-based biotechnology company developing diagnostic products aimed at improving patient health. The firm has two FDA-cleared tests for rapid detection of sepsis-causing pathogens from blood samples. It is expanding its in vitro diagnostics portfolio to address sepsis, hemostasis, bacterial infections, and Lyme disease, reflecting a focus on areas with high unmet medical need. The company relies on a proprietary diagnostic platform to support earlier, targeted treatment decisions and to help reduce hospital mortality and overall healthcare costs. Its customers include hospitals and other healthcare providers seeking rapid diagnostic results to guide treatment, and it maintains distribution and supplier relationships to support product access. In Oct 2024 the company launched the T2Lyme Panel, with plans to offer it as a laboratory-developed test in early 2025.